“allosteric-receptor-modulators” Archives

in
Entry Author Date Location
Sage’s Drug For Rare Epilepsy Shows Promise in Small Study 11/10/14 Boston
Sage Therapeutics Readies IPO Pitch to Develop CNS Drugs 06/18/14 Boston
Sage Therapeutics Nabs $20M Series B From Third Rock, Arch 10/16/13 Boston
Sage Wins $10M Grant to Push Fragile X Treatment Into Clinic 07/31/13 Boston
Third Rock Launches Sage Therapeutics with $35M Series A and Plan to Tackle Brain Diseases 10/18/11 Boston
Page 1 of 1